Prelude Therapeutics Incorporated (PRLD) Earnings Per Share (EPS)
Prelude Therapeutics Incorporated (PRLD) diluted earnings per share by fiscal period. Track EPS in Excel with MarketXLS.
EPS (Earnings Per Share) Data
| Period | Diluted EPS (USD) |
|---|---|
| 2020-12-31 | -$4.56 |
| 2021-12-31 | -$2.43 |
| 2022-12-31 | -$2.44 |
| 2023-12-31 | -$2.02 |
| 2024-12-31 | -$1.68 |
| 2025-12-31 | -$1.29 |
How PRLD compares with sector peers
| Symbol | Company | Diluted EPS (latest fiscal year) |
|---|---|---|
| ALT | Altimmune Inc. | -$1.00 |
| RFL | Rafael Holdings Inc. Class B | -$1.04 |
| ACHV | Achieve Life Sciences Inc. | -$1.25 |
| XBIT | XBiotech Inc. | -$1.49 |
| VERU | Veru Inc. | -$1.55 |
These are five companies in the same sector as PRLD with a comparable annual diluted earnings per share. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Prelude Therapeutics Incorporated Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =EarningsPerShare("PRLD")
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | PRLD | $5.55 | +3.54% | 0.45M |
| 3 | ||||
| 4 | ||||
| 5 |